FDA advisers vote to take Vicodin, Percocet off market:  A government advisory panel voted Tuesday to recommend eliminating prescription drugs that combine acetaminophen with narcotics -- such as Vicodin and Percocet -- because of their risk for overdose and for severe liver injury.  ------  Hydroxycut products recalled due to liver injuries:  Iovate Health Sciences recalls several Hydroxycut products after FDA issues a consumer warning to discontinue use due to liver damage.  ------  Wyeth Pharmaceuticals loses Supreme Court case:  Supreme Court rules that federal labeling laws do not preempt a drug firm from being sued

Gadolinium MRI / MRA Causes Nephrogenic Systemic Fibrosis (a skin and tissue condition) in Kidney Disease patients

 

Gadolinium

Gadolinium Side Effects

NSF / NFD

Gadolinium Lawsuits

Gadolinium Lawyers

 

Larry Gornick has been appointed by U.S. District Judge Dan Aaron Polster to the national Gadolinium litigation plaintiff's steering committee  >> read article MRI Side Effects Gadolinium MRI Causes NSF/NFD  >> read article PressMethod MRI Dye Causes Skin Disease  >> read article 7 News Boston - Special Report NSF attorney Larry Gornick appears on Boston area news discussing dangers of gadolinium MRI Dye  >> read article  >> Watch the video LegalNewsline.com Suit against Bayer, GE claims chemical compound is toxic  >> read article The Recorder Patient Sues Over Dyes From Imaging  >> read article Daily Journal One Plaintiff Suit at a Time  >> read article

Gadolinium is a chemical element used in image contrast agents during magnetic resonance imaging (MRI) and magnetic resonance angiography (MRA) procedures. Once injected, gadolinium-based contrast agents accumulate in abnormal tissues of the brain and body. This accumulation provides a greater contrast between normal and abnormal tissues, allowing doctors to better locate uncommon cell growths and tumors. Recently this drug has come under scrutiny by the Food and Drug Administration due to gadolinium side effects such as nephrogenic systemic fibrosis / nephrogenic fibrosing dermopathy (NSF/NFD).

FDA Black Box Warning for Gadolinium

In May, 2007 the Food and Drug Administration demanded that manufacturers of gadolinium-based contrast agents include “black box warnings” and extensive warning information in the drugs’ literature and packaging. These warnings were a result of well-documented cases linking nephrogenic systemic fibrosis / nephrogenic fibrosing dermopathy (NSF/NFD) to gadolinium exposure patients who suffer from severe kidney disorders and have been exposed to gadolinium-based contrast agents.

Nephrogenic Systemic Fibrosis / Nephrogenic Fibrosing Dermopathy (NSF/NFD)

Nephrogenic systemic fibrosis (NSF) and nephrogenic fibrosing dermopathy (NFD) is a disease-causing fibrosis of the skin and connective tissues. Sufferers may experience thickening of the skin, and fibrosis may develop in the diaphragm, thigh muscles, lower abdomen and lung vessels. Over time the debilitating effects of the disease worsen and sometimes cause death.

Currnetly there are a variety of treatments being utilitzed for NSF/NFD patients including, but not limited to:

• Photopheresis (ECP)
• Gleevac (imatinib mesylate)
• Oral Steroids (such as Prednisone)
• Pentoxyfilline
• Plasmapheresis
• Physical Therapy
• Reduced EPO dosage
• Thalidomide
• Topical Dovonex

FDA reports have shown that people can develop these gadolinium side effects after a single injection of a gadolinium-based contrast agent. There are five gadolinium-based contrast agents currently available, and their respective manufacturers may not have fully informed doctors and patients about the risk of NSF/NFD. This negligence may result in the drug manufacturers being required to compensate individuals who have become afflicted with NSF/NFD due to the use these agents.

If you or someone you know suffers from NSF/NFD and has been given a gadolinium-based contrast agent prior to an MRI or MRA, contact the law offices of Levin, Simes, Kaiser & Gornick at (877) LSKG-LAW to learn more about your legal rights and the possibility of compensation.

Gadolinium-Based Contrast Agents Currently in Use

Since 1988, the FDA has approved the use of five gadolinium-based contrast agents during MRI and MRA procedures:

• Magnevist (gadopentetate dimeglumine), manufactured by Bayer Healthcare.
• MultiHance (gadobenate dimeglumine), manufactured by Bracco.
• Omniscan (gadodiamide), manufactured by GE Healthcare.
• OptiMARK (gadoversetamide), manufactured by Mallinckrodt.
• ProHance (gadoteridol), manufactured by Bracco.

Causes and Symptoms of NSF/NFD

These side effects of gadolinium were discovered in 1997. The patients at highest risk suffer from an acute or chronic renal condition that causes the kidneys to insufficiently filter waste from the bloodstream. Other associated conditions that can cause NSF/NFD include kidney dysfunction due to hepatorenal syndrome or complications surrounding a liver transplant.
There are several symptoms associated with NSF/NFD, including:

• Swelling, hardening and tightening of the skin.
• Reddened or darkened patches on the skin.
• Raised yellow spots on the whites of the eyes.
• Joint stiffness.
• Deep pains in the hip bones or ribs.

Gadolinium Lawsuits

The failure of drug manufacturers to properly inform doctors and patients about the harmful side effects of these drugs illustrates their disregard for the well-being of consumers. Many gadolinium lawsuits have been brought against these companies due to the fact they may be liable for any illness or death caused by their gadolinium-based image contrasting agents. People who have been exposed to these drugs and are suffering from NSF/NFD symptoms should contact the gadolinium attorneys of Levin, Simes, Kaiser & Gornick at (877) LSKG-LAW to better understand their rights and explore any opportunities for compensation.

*indicates required field




comments
Don't enter anything here:  

 

 

Levin Simes Kaiser & Gornick, LLP
44 Montgomery Street, 36th floor
San Francisco, CA 94104

Ph: 1-877-LSKG-LAW
(1-877-575-4529)
Fax: 415-981-1270